SLGC
Somalogic Inc
19.10$
-0.4%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| – | +240.0% | +191.4% | -8.3% | |
| – | +288.1% | +198.1% | -15.9% | |
| – | +1,073.1% | +166.4% | -4.0% | |
| – | +349.8% | +221.0% | -18.0% | |
| – | +315.2% | -2.1% | -0.4% | |
| – | -16.7% | +59.7% | +23.9% | |
| – | -31.4% | +144.2% | +104.7% | |
| – | – | – | – | |
| – | – | – | – | |
| – | +10.9% | +66.9% | -9.8% | |
| – | +99.9% | +64.6% | +48.0% | |
| – | – | -97.3% | +3,653.0% | |
| – | +133.9% | +113.6% | +11.3% | |
| – | – | – | – | |
| – | +810.5% | +229.2% | -8.1% | |
| – | – | – | – | |
| – | +0.0% | -24.3% | +34.1% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.